Cargando…

Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway

Diabetic nephropathy (DN) has become the major cause of end-stage renal disease increasing the mortality risk of diabetes. Research has demonstrated that the oxidative damage and apoptosis of renal tubular cells is present during DN. Astragaloside IV (AS-IV) has been widely used for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Guo, Hong-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489012/ https://www.ncbi.nlm.nih.gov/pubmed/31086575 http://dx.doi.org/10.3892/etm.2019.7495

Ejemplares similares

Astragaloside IV ameliorates high glucose-induced renal tubular epithelial-mesenchymal transition by blocking mTORC1/p70S6K signaling in HK-2 cells
por: Chen, Xiao, et al.
Publicado: (2019)

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway
por: Li, Lei, et al.
Publicado: (2018)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
por: Sun, Chuang, et al.
Publicado: (2021)

Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway
por: Liu, Zhuanghua, et al.
Publicado: (2022)

Astragaloside IV Ameliorates Streptozotocin Induced Pancreatic β-Cell Apoptosis and Dysfunction Through SIRT1/P53 and Akt/GSK3β/Nrf2 Signaling Pathways
por: Lin, Yuqiong, et al.
Publicado: (2022)

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure
por: Sui, Yan-Bo, et al.
Publicado: (2020)

ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β(1) pathway
por: Jiang, Mingxia, et al.
Publicado: (2017)

Astragaloside IV attenuates lipopolysaccharide induced liver injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation
por: Sun, Yuxia, et al.
Publicado: (2023)

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway
por: Zhang, Zhijie, et al.
Publicado: (2018)

Astragaloside IV Alleviates Ammonia-Induced Apoptosis and Oxidative Stress in Bovine Mammary Epithelial Cells
por: Wang, Fengge, et al.
Publicado: (2019)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
por: Gao, Ping, et al.
Publicado: (2021)

Baicalin Ameliorates H(2)O(2) Induced Cytotoxicity in HK-2 Cells through the Inhibition of ER Stress and the Activation of Nrf2 Signaling
por: Lin, Miao, et al.
Publicado: (2014)

Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
por: Su, Yanyan, et al.
Publicado: (2022)

Astragaloside IV alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2/HO-1 signaling pathway
por: Zhang, Chunlei, et al.
Publicado: (2023)

Astragaloside IV protects RGC-5 cells against oxidative stress
por: Hao, Ming, et al.
Publicado: (2018)

Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice
por: Zhou, Ling, et al.
Publicado: (2020)

Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
por: Gui, Dingkun, et al.
Publicado: (2012)

Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC‐1α to reduce apoptosis in vitro and in vivo
por: Xie, Mingxia, et al.
Publicado: (2023)

Astragaloside IV ameliorates endoplasmic reticulum stress-induced apoptosis of Aβ25-35-treated PC12 cells by inhibiting the p38 MAPK signaling pathway
por: Ma, Yuhong, et al.
Publicado: (2019)

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
por: Li, Ziyu, et al.
Publicado: (2022)

Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
por: Qin, Shumin, et al.
Publicado: (2019)

Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway
por: Jin, Hualiang, et al.
Publicado: (2017)

Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose-treated HK-2 cells
por: Chen, Ping, et al.
Publicado: (2018)

Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
por: Nie, Pei, et al.
Publicado: (2019)

Cyclic helix B peptide protects HK-2 cells from oxidative stress by inhibiting ER stress and activating Nrf2 signalling and autophagy
por: Li, Long, et al.
Publicado: (2017)

Pinocembrin ameliorates lipopolysaccharide-induced HK-2 cell apoptosis and inflammation by regulating endoplasmic reticulum stress
por: Zhang, Yu, et al.
Publicado: (2022)

Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer’s disease via inhibiting NF-κB signaling pathway
por: He, Li, et al.
Publicado: (2023)

Pyruvate alleviates high glucose‐induced endoplasmic reticulum stress and apoptosis in HK‐2 cells
por: Zhang, Xiao Meng, et al.
Publicado: (2020)

Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2017)

Ketamine ameliorates oxidative stress-induced apoptosis in experimental traumatic brain injury via the Nrf2 pathway
por: Liang, Jinwei, et al.
Publicado: (2018)

Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK/Nrf2 signaling pathway
por: Huang, Luyan, et al.
Publicado: (2022)

Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway
por: Zhang, Xiao‐Qing, et al.
Publicado: (2019)

Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice
por: Zhang, Yaxuan, et al.
Publicado: (2022)

Zhibaidihuang Decoction Ameliorates Cell Oxidative Stress by Regulating the Keap1-Nrf2-ARE Signalling Pathway
por: Wu, Pingping, et al.
Publicado: (2020)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
por: Liang, Xiao-yu, et al.
Publicado: (2021)

Astragaloside IV protects against apoptosis in human degenerative chondrocytes through autophagy activation
por: Liu, Jianhong, et al.
Publicado: (2017)

Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway
por: Liu, Hong-Shuai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1g8sa2do3g5b0ke1oq3gcdgg6g